Biotech Investment Showcase & Start Up Slam
May 22 - 23, 2018 - London UKOxford Global
d.dalby@oxfordglobal.co.uk
Phone:01865248455
The 2018 Biotech Investment showcase is the UK and Europe’s most focussed and leading-edge funding, investment and partnering forum in the biotech sector, hosting over 300 attendees. Leading VC funds, investors, hedge funds, emerging successful biotech spinoffs, early stage biotech discovery and clinical companies and KOLs in the sector will be attending this one of a kind showcase event on the 22nd & 23rd May 2018 in London. The event will help to identify key technological and scientific investment areas and offers a unique networking, partnering and business development opportunity for those involved. What does the showcase consist of? Biotech Investment Conference Programme and Showcase * An educational programme with over 60 presentations, postulating topics on scientific, technological and investment growth in the industry * Over 50 biotech spinoffs, early stage discovery and clinical company product presentations during the 2 days * Two dedicated Startup Slam Sessions, supported by a 20-strong expert judging faculty Networking Opportunities and Scheduled Business Partnering Meetings *Over 35 scheduled business partnering meetings Exhibition area with coffee and lunch breaks * Poster presentation spotlights * Pre-dinner reception and networking drinks Corporate Gala Dinner and Awards * Event gala dinner and Awards ceremony * Live polling on industry hot topics throughout the evening * Supporting Cancer Research UK Start Up Slam At the showcase event, there are two dedicated sessions on the agenda for start-up entrepreneurs or scientists to present new products and research in front of leading pharma/biotech venture companies, VCs and Technology Transfer offices. If you are developing an innovative product or technology in the following areas, please contact marketing@oxfordglobal.co.uk * NGS/Single Cell/Genomics Technologies/dPCR/Microfluidics * Microbiome Discovery and Development * Pharma Technologies, Artificial Intelligence, Medical Devices and Digital Health * Immuno-Oncology and Immuno-Therapy Drug Discovery and Development * Biomarkers/Precision Medicine/ Liquid Biopsy in Drug and Clinical Development * Proteins, Antibodies, Cell Therapeutic Development